EUVIMEDEUVIMED entdecken
Vergleichsstudie

Alternative TMA-93 version demonstrates comparable performance and discriminative accuracy in early Alzheimer's disease

José Enrique Arriola-Infante iD, Ernesto García-Roldán iD, David García-Solís, Jose Antonio Lojo-Ramírez iD, Alba Marta Marín-Cabañas, Andrea Luque-Tirado, Ángela Almodóvar-Sierra, María Bernal Sánchez-Arjona, Didier Maillet, Emilio Franco-Macías iD

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251386479 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von José Enrique Arriola-Infante und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Torrecárdenas University Hospital, Almería, Spain. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Neuropsychological Tests. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The TMA-93 is a brief memory test shown to be accurate for early Alzheimer's disease (AD) diagnosis. Normative data are available, and biomarker-based cut-offs have been established.

Objective

To develop an alternative version of the TMA-93 and compare its performance with the original.

Methods

We prospectively recruited cognitively-unimpaired healthy controls (HC) and patients with mild cognitive impairment or mild dementia who had available AD biomarkers, all aged ≥50 years or older. HC participants received either version A or B of the TMA-93 in alternating order. Patients were administered both versions in a counterbalanced design—one before and the other after biomarker testing (interval

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionNeuropsychological TestsHumansFemaleMaleAgedMiddle AgedReproducibility of ResultsBiomarkersAged, 80 and overProspective Studies

Stichwörter der Autor:innen

Alzheimer's diseasealternate formbiomarkerscognitionmemoryneuropsychological tests

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
  • Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Memory Unit, Department of Neurology, Virgen del Rocío University Hospital, Sevilla, Spain.
  • Nuclear Medicine Unit, Virgen del Rocío University Hospital, Sevilla, Spain.
  • Service de Neurologie à orientation oncologique, Hôpital Saint-Louis (AP-HP), Paris, France.

ORCID-Profile: José Enrique Arriola-Infante, Ernesto García-Roldán, Jose Antonio Lojo-Ramírez, Emilio Franco-Macías

Zitieren

APA

Arriola-Infante, J. E., García-Roldán, E., García-Solís, D., Lojo-Ramírez, J. A., Marín-Cabañas, A. M., Luque-Tirado, A., Almodóvar-Sierra, Á., Bernal Sánchez-Arjona, M., Maillet, D., & Franco-Macías, E. (2025). Alternative TMA-93 version demonstrates comparable performance and discriminative accuracy in early Alzheimer's disease. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251386479

Vancouver

Arriola-Infante JE, García-Roldán E, García-Solís D, Lojo-Ramírez JA, Marín-Cabañas AM, Luque-Tirado A, et al. Alternative TMA-93 version demonstrates comparable performance and discriminative accuracy in early Alzheimer's disease. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251386479

BibTeX
@article{ArriolaInfante2025,
  author = {Arriola-Infante, José Enrique and García-Roldán, Ernesto and García-Solís, David and Lojo-Ramírez, Jose Antonio and Marín-Cabañas, Alba Marta and Luque-Tirado, Andrea and Almodóvar-Sierra, Ángela and Bernal Sánchez-Arjona, María and Maillet, Didier and Franco-Macías, Emilio},
  title = {Alternative TMA-93 version demonstrates comparable performance and discriminative accuracy in early Alzheimer's disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251386479}
}
Kostenlos starten →